页码:71
##删除换行1:<u>| |</u>Table 14 Severe Persistent Asthma

##删除换行1:<u>| |</u>Symptoms

【2】•Continual symptoms
•Frequent nighttime symptoms
•Limited physical activity

【3】•Frequent exacerbations

##删除换行1:<u>| |</u>Lung Function Tests

【5】•Peak flow (PEF) measurement ≤ 60% of predicted
•Forced expiratory volume (FEV 1 ) ≤ 60% predicted
•Peak flow (PEF) variablility > 30%

##删除换行1:<u>| |</u>Treatment ("Step 4")

【7】•All patients with asthma should be prescribed inhaled "quick-relief" bronchodilator therapy to be used on an as-needed basis. A shortacting inhaled β 2 agonist is the recommended "quick-relief" agent.

【8】•Up to three types of daily medication are required. Inhaled highdose corticosteroid preparations are mandatory. They are best combined with inhaled long-acting β 2 agonists. Corticosteroid tablets or syrup in the smallest dose required may also part of the daily maintenance regimen. Additional medications are discussed in the text.

【9】•"Rescue" steroid medication may be prescribed, along with steppedup therapy during exacerbations.

【10】•Adults as well as children with severe persistent asthma should be under the care of a physician who is an asthma specialist. instead be placed on a short-acting β 2 agonist medication taken by mouth (orally) in liquid or syrup form as an alternative, especially if inhalation of medication is unfeasible. It is important to remember that a need for increasing use of such quick-relief medicine reflects increasing asthma activity.

【11】All patients with severe persistent asthma should be under the care of a physician specializing in asthma care. Step 4 treatment includes the several-times-daily use of high-dose, inhaled corticosteroids combined with a long-acting, inhaled β 2 agonist. In addition, oral corticosteroid tablets may be required daily, or黄艳玲

====================================================================================================

oss://inf-beta/datasets/medical_books_v1130/100 Questions and Answers About Asthma (Claudia S. Plotte) (Z-Library).pdf
